際際滷shows by User: AnthonyRussell4 / http://www.slideshare.net/images/logo.gif 際際滷shows by User: AnthonyRussell4 / Sun, 14 Feb 2021 16:19:36 GMT 際際滷Share feed for 際際滷shows by User: AnthonyRussell4 Making Key Decisions in New Product Planning When Perfect Information is Not Available /slideshow/making-key-decisions-in-new-product-planning-when-perfect-information-is-not-available/242708556 nppsummit2021slides-fiercetemplate-abrvf-clean-210214161936
Presentation given at New Product Planning Summit 2021. Learning Objectives: * Review the types of decisions typically made in New Product Planning * Discuss the nature of information available to support decision-making in New Product Planning * Review the impact and context of decision-making in New Product Planning * Review potential approaches to assist in New Product Planning decision-making]]>
Presentation given at New Product Planning Summit 2021. Learning Objectives: * Review the types of decisions typically made in New Product Planning * Discuss the nature of information available to support decision-making in New Product Planning * Review the impact and context of decision-making in New Product Planning * Review potential approaches to assist in New Product Planning decision-making]]> Sun, 14 Feb 2021 16:19:36 GMT /slideshow/making-key-decisions-in-new-product-planning-when-perfect-information-is-not-available/242708556 AnthonyRussell4@slideshare.net(AnthonyRussell4) Making Key Decisions in New Product Planning When Perfect Information is Not Available AnthonyRussell4 Presentation given at New Product Planning Summit 2021. Learning Objectives: * Review the types of decisions typically made in New Product Planning * Discuss the nature of information available to support decision-making in New Product Planning * Review the impact and context of decision-making in New Product Planning * Review potential approaches to assist in New Product Planning decision-making <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/nppsummit2021slides-fiercetemplate-abrvf-clean-210214161936-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Presentation given at New Product Planning Summit 2021. Learning Objectives: * Review the types of decisions typically made in New Product Planning * Discuss the nature of information available to support decision-making in New Product Planning * Review the impact and context of decision-making in New Product Planning * Review potential approaches to assist in New Product Planning decision-making
Making Key Decisions in New Product Planning When Perfect Information is Not Available from Anthony Russell
]]> 301 0 https://cdn.slidesharecdn.com/ss_thumbnails/nppsummit2021slides-fiercetemplate-abrvf-clean-210214161936-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 New Product Planning in the Pharmaceutical Industry /slideshow/new-product-planning-in-the-pharmaceutical-industry/235588136 usc2020-nppoveriew-finalv2-200615002400
Lecture presented in the Competitive Intelligence and Pricing course as part of the University of Southern California Master of Science in Healthcare Decision Analysis program. Presented on June 14, 2020 at USC via Zoom. The lectures gives an overview of what new product planning is in the pharmaceutical industry, what tools are used during new product evaluations, and the key elements of a new product business case. The lecture includes a couple of case studies to be worked on by the class.]]>
Lecture presented in the Competitive Intelligence and Pricing course as part of the University of Southern California Master of Science in Healthcare Decision Analysis program. Presented on June 14, 2020 at USC via Zoom. The lectures gives an overview of what new product planning is in the pharmaceutical industry, what tools are used during new product evaluations, and the key elements of a new product business case. The lecture includes a couple of case studies to be worked on by the class.]]> Mon, 15 Jun 2020 00:24:00 GMT /slideshow/new-product-planning-in-the-pharmaceutical-industry/235588136 AnthonyRussell4@slideshare.net(AnthonyRussell4) New Product Planning in the Pharmaceutical Industry AnthonyRussell4 Lecture presented in the Competitive Intelligence and Pricing course as part of the University of Southern California Master of Science in Healthcare Decision Analysis program. Presented on June 14, 2020 at USC via Zoom. The lectures gives an overview of what new product planning is in the pharmaceutical industry, what tools are used during new product evaluations, and the key elements of a new product business case. The lecture includes a couple of case studies to be worked on by the class. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/usc2020-nppoveriew-finalv2-200615002400-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Lecture presented in the Competitive Intelligence and Pricing course as part of the University of Southern California Master of Science in Healthcare Decision Analysis program. Presented on June 14, 2020 at USC via Zoom. The lectures gives an overview of what new product planning is in the pharmaceutical industry, what tools are used during new product evaluations, and the key elements of a new product business case. The lecture includes a couple of case studies to be worked on by the class.
New Product Planning in the Pharmaceutical Industry from Anthony Russell
]]> 2837 0 https://cdn.slidesharecdn.com/ss_thumbnails/usc2020-nppoveriew-finalv2-200615002400-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 How and When to Kill a Program in New Product Planning /slideshow/how-and-when-to-kill-a-program-in-new-product-planning/201394903 npp2019presentation-vf-abr-11-15-2019-191204122501
Presented at the 4th New Product Planning Summit in Boston (Dec 2 -3 , 2019). Presentation covers why weak programs should be cut from pharmaceutical and biotech pipelines, what defines a "weak" program, and describes objective methods to evaluate programs to help prioritize assets.]]>
Presented at the 4th New Product Planning Summit in Boston (Dec 2 -3 , 2019). Presentation covers why weak programs should be cut from pharmaceutical and biotech pipelines, what defines a "weak" program, and describes objective methods to evaluate programs to help prioritize assets.]]> Wed, 04 Dec 2019 12:25:00 GMT /slideshow/how-and-when-to-kill-a-program-in-new-product-planning/201394903 AnthonyRussell4@slideshare.net(AnthonyRussell4) How and When to Kill a Program in New Product Planning AnthonyRussell4 Presented at the 4th New Product Planning Summit in Boston (Dec 2 -3 , 2019). Presentation covers why weak programs should be cut from pharmaceutical and biotech pipelines, what defines a "weak" program, and describes objective methods to evaluate programs to help prioritize assets. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/npp2019presentation-vf-abr-11-15-2019-191204122501-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Presented at the 4th New Product Planning Summit in Boston (Dec 2 -3 , 2019). Presentation covers why weak programs should be cut from pharmaceutical and biotech pipelines, what defines a &quot;weak&quot; program, and describes objective methods to evaluate programs to help prioritize assets.
How and When to Kill a Program in New Product Planning from Anthony Russell
]]> 255 1 https://cdn.slidesharecdn.com/ss_thumbnails/npp2019presentation-vf-abr-11-15-2019-191204122501-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 New Product Planning Strategies to Ensure Organizational Robustness for Launch /slideshow/new-product-planning-strategies-to-ensure-organizational-robustness-for-launch/188345914 russell-npppresentation-5thbiopharmalaunchsummit-vf-09-12-2019-191029220608
Presented at the Bio/Pharmaceutical Product Commercialization and Launch Roadmap event organized by CBI on October 29, 2019.]]>
Presented at the Bio/Pharmaceutical Product Commercialization and Launch Roadmap event organized by CBI on October 29, 2019.]]> Tue, 29 Oct 2019 22:06:08 GMT /slideshow/new-product-planning-strategies-to-ensure-organizational-robustness-for-launch/188345914 AnthonyRussell4@slideshare.net(AnthonyRussell4) New Product Planning Strategies to Ensure Organizational Robustness for Launch AnthonyRussell4 Presented at the Bio/Pharmaceutical Product Commercialization and Launch Roadmap event organized by CBI on October 29, 2019. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/russell-npppresentation-5thbiopharmalaunchsummit-vf-09-12-2019-191029220608-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Presented at the Bio/Pharmaceutical Product Commercialization and Launch Roadmap event organized by CBI on October 29, 2019.
New Product Planning Strategies to Ensure Organizational Robustness for Launch from Anthony Russell
]]> 295 3 https://cdn.slidesharecdn.com/ss_thumbnails/russell-npppresentation-5thbiopharmalaunchsummit-vf-09-12-2019-191029220608-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 New Product Planning and Medical Affairs /slideshow/new-product-planning-and-medical-affairs/175560344 masswest2019-abr-vf-09-11-2019-190924134236
A workshop presentation for Medical Affairs Strategic Summit West held in San Diego on September 23, 2019. The workshop covered the following learning objectives: * Understand the factors involved in selecting and prioritizing indications * Understand the importance of strategic market segmentation * Understand how Medical Affairs can be involved in the process of new product planning]]>
A workshop presentation for Medical Affairs Strategic Summit West held in San Diego on September 23, 2019. The workshop covered the following learning objectives: * Understand the factors involved in selecting and prioritizing indications * Understand the importance of strategic market segmentation * Understand how Medical Affairs can be involved in the process of new product planning]]> Tue, 24 Sep 2019 13:42:36 GMT /slideshow/new-product-planning-and-medical-affairs/175560344 AnthonyRussell4@slideshare.net(AnthonyRussell4) New Product Planning and Medical Affairs AnthonyRussell4 A workshop presentation for Medical Affairs Strategic Summit West held in San Diego on September 23, 2019. The workshop covered the following learning objectives: * Understand the factors involved in selecting and prioritizing indications * Understand the importance of strategic market segmentation * Understand how Medical Affairs can be involved in the process of new product planning <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/masswest2019-abr-vf-09-11-2019-190924134236-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> A workshop presentation for Medical Affairs Strategic Summit West held in San Diego on September 23, 2019. The workshop covered the following learning objectives: * Understand the factors involved in selecting and prioritizing indications * Understand the importance of strategic market segmentation * Understand how Medical Affairs can be involved in the process of new product planning
New Product Planning and Medical Affairs from Anthony Russell
]]> 287 3 https://cdn.slidesharecdn.com/ss_thumbnails/masswest2019-abr-vf-09-11-2019-190924134236-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Lifecycle Management in the Pharmaceutical Industry /slideshow/lifecycle-management-in-the-pharmaceutical-industry/130739837 ucsdfeb2019-lcm-abr-v4final-190206135428
Presented to students in the Drug Development and Product Management program at UC San Diego. Covers the rationale for lifecycle management is important. Includes case studies of successful implementation of lifecycle management. Presentation date: 2/5/2019.]]>
Presented to students in the Drug Development and Product Management program at UC San Diego. Covers the rationale for lifecycle management is important. Includes case studies of successful implementation of lifecycle management. Presentation date: 2/5/2019.]]> Wed, 06 Feb 2019 13:54:28 GMT /slideshow/lifecycle-management-in-the-pharmaceutical-industry/130739837 AnthonyRussell4@slideshare.net(AnthonyRussell4) Lifecycle Management in the Pharmaceutical Industry AnthonyRussell4 Presented to students in the Drug Development and Product Management program at UC San Diego. Covers the rationale for lifecycle management is important. Includes case studies of successful implementation of lifecycle management. Presentation date: 2/5/2019. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/ucsdfeb2019-lcm-abr-v4final-190206135428-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Presented to students in the Drug Development and Product Management program at UC San Diego. Covers the rationale for lifecycle management is important. Includes case studies of successful implementation of lifecycle management. Presentation date: 2/5/2019.
Lifecycle Management in the Pharmaceutical Industry from Anthony Russell
]]> 1842 4 https://cdn.slidesharecdn.com/ss_thumbnails/ucsdfeb2019-lcm-abr-v4final-190206135428-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 How to Work Effectively with Research Teams in New Product Planning /slideshow/how-to-work-effectively-with-research-teams-in-new-product-planning/125852080 npp2018presentation-v3-abr-11142018-final-181213221157
Presented at the 3rd New Product Planning Summit. The presentation was designed to help professionals in New Product Planning to present a case for why commercial strategy input is needed early in the process of developing new therapeutics. The presentation also includes suggested approaches and tools to help with effective engagement with Research teams.]]>
Presented at the 3rd New Product Planning Summit. The presentation was designed to help professionals in New Product Planning to present a case for why commercial strategy input is needed early in the process of developing new therapeutics. The presentation also includes suggested approaches and tools to help with effective engagement with Research teams.]]> Thu, 13 Dec 2018 22:11:56 GMT /slideshow/how-to-work-effectively-with-research-teams-in-new-product-planning/125852080 AnthonyRussell4@slideshare.net(AnthonyRussell4) How to Work Effectively with Research Teams in New Product Planning AnthonyRussell4 Presented at the 3rd New Product Planning Summit. The presentation was designed to help professionals in New Product Planning to present a case for why commercial strategy input is needed early in the process of developing new therapeutics. The presentation also includes suggested approaches and tools to help with effective engagement with Research teams. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/npp2018presentation-v3-abr-11142018-final-181213221157-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Presented at the 3rd New Product Planning Summit. The presentation was designed to help professionals in New Product Planning to present a case for why commercial strategy input is needed early in the process of developing new therapeutics. The presentation also includes suggested approaches and tools to help with effective engagement with Research teams.
How to Work Effectively with Research Teams in New Product Planning from Anthony Russell
]]> 266 5 https://cdn.slidesharecdn.com/ss_thumbnails/npp2018presentation-v3-abr-11142018-final-181213221157-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Performing Competitive Intelligence in a Pharmaceutical Company /slideshow/performing-competitive-intelligence-in-a-pharmaceutical-company/121949951 usccompetitiveintelligencetalk-final-10252018-181105151459
Workshop presented in the Competitive Intelligence and Pricing course as part of the University of Southern California Master of Science in Healthcare Decision Analysis program. Presented on Nov 4, 2018 at USC. The workshop gives an overview of what competitive intelligence is and how it is done in pharmaceutical companies. The workshop includes a couple of non-pharmaceutical exercises to help students learn how to write key intelligence questions and to work through a market simulation exercise. The workshop ends with a discussion on the various career pathways available within the competitive intelligence field.]]>
Workshop presented in the Competitive Intelligence and Pricing course as part of the University of Southern California Master of Science in Healthcare Decision Analysis program. Presented on Nov 4, 2018 at USC. The workshop gives an overview of what competitive intelligence is and how it is done in pharmaceutical companies. The workshop includes a couple of non-pharmaceutical exercises to help students learn how to write key intelligence questions and to work through a market simulation exercise. The workshop ends with a discussion on the various career pathways available within the competitive intelligence field.]]> Mon, 05 Nov 2018 15:14:59 GMT /slideshow/performing-competitive-intelligence-in-a-pharmaceutical-company/121949951 AnthonyRussell4@slideshare.net(AnthonyRussell4) Performing Competitive Intelligence in a Pharmaceutical Company AnthonyRussell4 Workshop presented in the Competitive Intelligence and Pricing course as part of the University of Southern California Master of Science in Healthcare Decision Analysis program. Presented on Nov 4, 2018 at USC. The workshop gives an overview of what competitive intelligence is and how it is done in pharmaceutical companies. The workshop includes a couple of non-pharmaceutical exercises to help students learn how to write key intelligence questions and to work through a market simulation exercise. The workshop ends with a discussion on the various career pathways available within the competitive intelligence field. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/usccompetitiveintelligencetalk-final-10252018-181105151459-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Workshop presented in the Competitive Intelligence and Pricing course as part of the University of Southern California Master of Science in Healthcare Decision Analysis program. Presented on Nov 4, 2018 at USC. The workshop gives an overview of what competitive intelligence is and how it is done in pharmaceutical companies. The workshop includes a couple of non-pharmaceutical exercises to help students learn how to write key intelligence questions and to work through a market simulation exercise. The workshop ends with a discussion on the various career pathways available within the competitive intelligence field.
Performing Competitive Intelligence in a Pharmaceutical Company from Anthony Russell
]]> 5972 12 https://cdn.slidesharecdn.com/ss_thumbnails/usccompetitiveintelligencetalk-final-10252018-181105151459-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Building a Business Case for New Product Planning in a Small Company Environment /slideshow/building-a-business-case-for-new-product-planning-in-a-small-company-environment/83675326 nppsummit2017-abr-fullfinal11172017-171208212745
Presented at the 2nd New Product Planning Summit by ExL Events in Boston (Dec 8, 2017). An overview of why commercial strategy is needed early in product development. As pressures continue to mount in drug development (crowded markets, payer and access issues, etc.), it is becoming critical to focus on the early stages of drug development. Working early with research and development teams to evaluate the commercial viability of programs will benefit companies of all sizes to maximize their portfolio of therapeutic candidates.]]>
Presented at the 2nd New Product Planning Summit by ExL Events in Boston (Dec 8, 2017). An overview of why commercial strategy is needed early in product development. As pressures continue to mount in drug development (crowded markets, payer and access issues, etc.), it is becoming critical to focus on the early stages of drug development. Working early with research and development teams to evaluate the commercial viability of programs will benefit companies of all sizes to maximize their portfolio of therapeutic candidates.]]> Fri, 08 Dec 2017 21:27:45 GMT /slideshow/building-a-business-case-for-new-product-planning-in-a-small-company-environment/83675326 AnthonyRussell4@slideshare.net(AnthonyRussell4) Building a Business Case for New Product Planning in a Small Company Environment AnthonyRussell4 Presented at the 2nd New Product Planning Summit by ExL Events in Boston (Dec 8, 2017). An overview of why commercial strategy is needed early in product development. As pressures continue to mount in drug development (crowded markets, payer and access issues, etc.), it is becoming critical to focus on the early stages of drug development. Working early with research and development teams to evaluate the commercial viability of programs will benefit companies of all sizes to maximize their portfolio of therapeutic candidates. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/nppsummit2017-abr-fullfinal11172017-171208212745-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Presented at the 2nd New Product Planning Summit by ExL Events in Boston (Dec 8, 2017). An overview of why commercial strategy is needed early in product development. As pressures continue to mount in drug development (crowded markets, payer and access issues, etc.), it is becoming critical to focus on the early stages of drug development. Working early with research and development teams to evaluate the commercial viability of programs will benefit companies of all sizes to maximize their portfolio of therapeutic candidates.
Building a Business Case for New Product Planning in a Small Company Environment from Anthony Russell
]]> 363 5 https://cdn.slidesharecdn.com/ss_thumbnails/nppsummit2017-abr-fullfinal11172017-171208212745-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 https://public.slidesharecdn.com/v2/images/profile-picture.png https://cdn.slidesharecdn.com/ss_thumbnails/nppsummit2021slides-fiercetemplate-abrvf-clean-210214161936-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/making-key-decisions-in-new-product-planning-when-perfect-information-is-not-available/242708556 Making Key Decisions i... https://cdn.slidesharecdn.com/ss_thumbnails/usc2020-nppoveriew-finalv2-200615002400-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/new-product-planning-in-the-pharmaceutical-industry/235588136 New Product Planning i... https://cdn.slidesharecdn.com/ss_thumbnails/npp2019presentation-vf-abr-11-15-2019-191204122501-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/how-and-when-to-kill-a-program-in-new-product-planning/201394903 How and When to Kill a...